Nuveen Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $32.3M | Buy |
595,581
+14,792
| +3% | +$801K | 0.01% | 872 |
|
|
2024
Q3 | $29.3M | Buy |
580,789
+59,076
| +11% | +$2.98M | 0.01% | 943 |
|
|
2024
Q2 | $22.9M | Buy |
521,713
+325,842
| +166% | +$14.3M | 0.01% | 1040 |
|
|
2024
Q1 | $9.84M | Sell |
195,871
-444
| -0.2% | -$22.3K | ﹤0.01% | 1593 |
|
|
2023
Q4 | $11.9M | Buy |
196,315
+56,315
| +40% | +$3.4M | ﹤0.01% | 1485 |
|
|
2023
Q3 | $7.98M | Hold |
140,000
| – | – | ﹤0.01% | 1608 |
|
|
2023
Q2 | $7.14M | Buy |
+140,000
| New | +$7.14M | ﹤0.01% | 1706 |
|